DUSP9 and breast cancer: A potential protumourigenic role of DUSP9 has been suggested by findings showing that HIF1-dependent regulation of MAPK signalling via DUSP9 contributes to the enrichment of chemotherapy-induced BC stem cells (BCSC) in MDA-MB-231 and SUM-159 TNBC cells.